F2R and breast carcinoma: This group has demonstrated that PAR1-induced breast tumor in a mouse model, in vivo, is blocked by the cell-penetrating lipopeptide “pepducin,” P1pal-7, which is a potent inhibitor of cell viability in breast carcinoma cells expressing PAR1.